Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT00673205




Registration number
NCT00673205
Ethics application status
Date submitted
2/05/2008
Date registered
7/05/2008
Date last updated
10/12/2010

Titles & IDs
Public title
(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer
Scientific title
A Randomized, Double-Blind, Parallel-Group Trial Comparing Bicalutamide (Casodex) 150mg Once Daily With Placebo in Patients With Non-metastatic Prostate Cancer
Secondary ID [1] 0 0
7054IL/0024
Secondary ID [2] 0 0
D6876C00024
Universal Trial Number (UTN)
Trial acronym
Capri
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Non-Metastatic Prostate Cancer 0 0
Condition category
Condition code
Cancer 0 0 0 0
Prostate

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Bicalutamide

Placebo comparator: A -

Active comparator: B -


Treatment: Drugs: Bicalutamide
150mg p.o. daily
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Time to clinical progression
Timepoint [1] 0 0
Throughout study period
Primary outcome [2] 0 0
Tolerability in terms of adverse events and laboratory parameters
Timepoint [2] 0 0
Throughout study period
Secondary outcome [1] 0 0
Survival
Timepoint [1] 0 0
Throughout study period
Secondary outcome [2] 0 0
Time to treatment failure
Timepoint [2] 0 0
Throughout study period
Secondary outcome [3] 0 0
Prostate-specific antigen
Timepoint [3] 0 0
Initial study period up to 2005 amended protocol

Eligibility
Key inclusion criteria
* Clinical diagnosis of non-metastatic cancer of the prostate gland
* Patient to be 18 years and above
Minimum age
18 Years
Maximum age
No limit
Sex
Males
Can healthy volunteers participate?
No
Key exclusion criteria
* Previous systemic therapy for prostate cancer
* Previous history of another form of cancer (not prostate) within 5 years of study start.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s

The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/09/1995
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/08/2008
Sample size
Target
Accrual to date
Final
3588
Recruitment in Australia
Recruitment state(s)
QLD,VIC
Recruitment hospital [1] 0 0
Research Site - Wooloongabba
Recruitment hospital [2] 0 0
Research Site - East Melbourne
Recruitment postcode(s) [1] 0 0
- Wooloongabba
Recruitment postcode(s) [2] 0 0
- East Melbourne
Recruitment outside Australia
Country [1] 0 0
Austria
State/province [1] 0 0
Graz
Country [2] 0 0
Austria
State/province [2] 0 0
Linz
Country [3] 0 0
Austria
State/province [3] 0 0
Mistelbach
Country [4] 0 0
Austria
State/province [4] 0 0
Oberwart
Country [5] 0 0
Austria
State/province [5] 0 0
St. Polten
Country [6] 0 0
Belgium
State/province [6] 0 0
Antwerpen
Country [7] 0 0
Belgium
State/province [7] 0 0
Brugge
Country [8] 0 0
Belgium
State/province [8] 0 0
Brussels
Country [9] 0 0
Belgium
State/province [9] 0 0
Gent
Country [10] 0 0
Belgium
State/province [10] 0 0
Kortrijk
Country [11] 0 0
Belgium
State/province [11] 0 0
Leuven
Country [12] 0 0
Belgium
State/province [12] 0 0
Mons
Country [13] 0 0
Belgium
State/province [13] 0 0
Oostende
Country [14] 0 0
Belgium
State/province [14] 0 0
Seraing
Country [15] 0 0
Czech Republic
State/province [15] 0 0
Brno
Country [16] 0 0
Czech Republic
State/province [16] 0 0
Hradec Kralove
Country [17] 0 0
Czech Republic
State/province [17] 0 0
Olomouc
Country [18] 0 0
Czech Republic
State/province [18] 0 0
Praha 4
Country [19] 0 0
Czech Republic
State/province [19] 0 0
Praha 5
Country [20] 0 0
Germany
State/province [20] 0 0
Berlin
Country [21] 0 0
Germany
State/province [21] 0 0
Bonn
Country [22] 0 0
Germany
State/province [22] 0 0
Dresden
Country [23] 0 0
Germany
State/province [23] 0 0
Freiburg
Country [24] 0 0
Germany
State/province [24] 0 0
Heidelberg
Country [25] 0 0
Germany
State/province [25] 0 0
Jena
Country [26] 0 0
Germany
State/province [26] 0 0
Lubeck
Country [27] 0 0
Germany
State/province [27] 0 0
Ludenscheid
Country [28] 0 0
Germany
State/province [28] 0 0
Mannheim
Country [29] 0 0
Germany
State/province [29] 0 0
Munchen
Country [30] 0 0
Germany
State/province [30] 0 0
Regensburg
Country [31] 0 0
Germany
State/province [31] 0 0
Sigmaringen
Country [32] 0 0
Hungary
State/province [32] 0 0
Budapest
Country [33] 0 0
Hungary
State/province [33] 0 0
Miskolc
Country [34] 0 0
Hungary
State/province [34] 0 0
Nyiregyhaza
Country [35] 0 0
Ireland
State/province [35] 0 0
Dublin 4
Country [36] 0 0
Ireland
State/province [36] 0 0
Dublin 7
Country [37] 0 0
Israel
State/province [37] 0 0
Haifa
Country [38] 0 0
Israel
State/province [38] 0 0
Petach Tikva
Country [39] 0 0
Israel
State/province [39] 0 0
Tel-aviv
Country [40] 0 0
Israel
State/province [40] 0 0
Tel-hashomer
Country [41] 0 0
Italy
State/province [41] 0 0
BA
Country [42] 0 0
Italy
State/province [42] 0 0
BG
Country [43] 0 0
Italy
State/province [43] 0 0
BL
Country [44] 0 0
Italy
State/province [44] 0 0
BO
Country [45] 0 0
Italy
State/province [45] 0 0
BS
Country [46] 0 0
Italy
State/province [46] 0 0
CO
Country [47] 0 0
Italy
State/province [47] 0 0
FO
Country [48] 0 0
Italy
State/province [48] 0 0
FR
Country [49] 0 0
Italy
State/province [49] 0 0
MO
Country [50] 0 0
Italy
State/province [50] 0 0
PR
Country [51] 0 0
Italy
State/province [51] 0 0
SI
Country [52] 0 0
Italy
State/province [52] 0 0
TO
Country [53] 0 0
Italy
State/province [53] 0 0
TV
Country [54] 0 0
Italy
State/province [54] 0 0
UD
Country [55] 0 0
Italy
State/province [55] 0 0
VA
Country [56] 0 0
Italy
State/province [56] 0 0
VE
Country [57] 0 0
Italy
State/province [57] 0 0
Roma
Country [58] 0 0
Mexico
State/province [58] 0 0
Mexico
Country [59] 0 0
Netherlands
State/province [59] 0 0
Amsterdam
Country [60] 0 0
Netherlands
State/province [60] 0 0
Breda
Country [61] 0 0
Netherlands
State/province [61] 0 0
Capelle A/d Ijssel
Country [62] 0 0
Netherlands
State/province [62] 0 0
Eindhoven
Country [63] 0 0
Netherlands
State/province [63] 0 0
Enschede
Country [64] 0 0
Netherlands
State/province [64] 0 0
Gouda
Country [65] 0 0
Netherlands
State/province [65] 0 0
Heerlen
Country [66] 0 0
Netherlands
State/province [66] 0 0
Maastricht
Country [67] 0 0
Netherlands
State/province [67] 0 0
Nijmegen
Country [68] 0 0
Netherlands
State/province [68] 0 0
Roosendaal
Country [69] 0 0
Netherlands
State/province [69] 0 0
Rotterdam
Country [70] 0 0
Netherlands
State/province [70] 0 0
Spijkenisse
Country [71] 0 0
Netherlands
State/province [71] 0 0
Utrecht
Country [72] 0 0
Poland
State/province [72] 0 0
Warszawa
Country [73] 0 0
Poland
State/province [73] 0 0
Wroclaw
Country [74] 0 0
Portugal
State/province [74] 0 0
Almada
Country [75] 0 0
Portugal
State/province [75] 0 0
Coimbra
Country [76] 0 0
Portugal
State/province [76] 0 0
Lisboa
Country [77] 0 0
Portugal
State/province [77] 0 0
Porto
Country [78] 0 0
Portugal
State/province [78] 0 0
Vila Nova de Gaia
Country [79] 0 0
South Africa
State/province [79] 0 0
Cape Town
Country [80] 0 0
South Africa
State/province [80] 0 0
Bloemfontein
Country [81] 0 0
South Africa
State/province [81] 0 0
Durban
Country [82] 0 0
South Africa
State/province [82] 0 0
George
Country [83] 0 0
South Africa
State/province [83] 0 0
Johannesburg
Country [84] 0 0
South Africa
State/province [84] 0 0
Pietermarizberg
Country [85] 0 0
South Africa
State/province [85] 0 0
Pretoria
Country [86] 0 0
Spain
State/province [86] 0 0
Andalucia
Country [87] 0 0
Spain
State/province [87] 0 0
Asturias
Country [88] 0 0
Spain
State/province [88] 0 0
Castilla La Mancha
Country [89] 0 0
Spain
State/province [89] 0 0
Castilla Leon
Country [90] 0 0
Spain
State/province [90] 0 0
Cataluna
Country [91] 0 0
Spain
State/province [91] 0 0
Comunidad de Madrid
Country [92] 0 0
Spain
State/province [92] 0 0
Comunidad Valenciana
Country [93] 0 0
Spain
State/province [93] 0 0
Galicia
Country [94] 0 0
Spain
State/province [94] 0 0
Navarra
Country [95] 0 0
Spain
State/province [95] 0 0
Pais Vasco
Country [96] 0 0
United Kingdom
State/province [96] 0 0
Berkshire
Country [97] 0 0
United Kingdom
State/province [97] 0 0
Essex
Country [98] 0 0
United Kingdom
State/province [98] 0 0
Hertfordshire
Country [99] 0 0
United Kingdom
State/province [99] 0 0
London
Country [100] 0 0
United Kingdom
State/province [100] 0 0
Northern Ireland
Country [101] 0 0
United Kingdom
State/province [101] 0 0
Somerset
Country [102] 0 0
United Kingdom
State/province [102] 0 0
South Wales
Country [103] 0 0
United Kingdom
State/province [103] 0 0
Sussex
Country [104] 0 0
United Kingdom
State/province [104] 0 0
West Midlands
Country [105] 0 0
United Kingdom
State/province [105] 0 0
Bolton
Country [106] 0 0
United Kingdom
State/province [106] 0 0
Bristol
Country [107] 0 0
United Kingdom
State/province [107] 0 0
Cardiff
Country [108] 0 0
United Kingdom
State/province [108] 0 0
Cleveland
Country [109] 0 0
United Kingdom
State/province [109] 0 0
Edinburgh
Country [110] 0 0
United Kingdom
State/province [110] 0 0
Falkirk
Country [111] 0 0
United Kingdom
State/province [111] 0 0
Hull
Country [112] 0 0
United Kingdom
State/province [112] 0 0
Kent
Country [113] 0 0
United Kingdom
State/province [113] 0 0
Leeds
Country [114] 0 0
United Kingdom
State/province [114] 0 0
Manchester
Country [115] 0 0
United Kingdom
State/province [115] 0 0
Plymouth
Country [116] 0 0
United Kingdom
State/province [116] 0 0
Sheffield
Country [117] 0 0
United Kingdom
State/province [117] 0 0
Shrewsbury

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
AstraZeneca
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Manfred P Wirth, Professor
Address 0 0
Technical University of Dresden, Germany
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT00673205